{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T20:53:20Z","timestamp":1788555200438,"version":"build-2803163510"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T00:00:00Z","timestamp":1655683200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Hepatol Commun"],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The effects of acute portal hypertension (PHT), which is reported as poor prognostic factors in patients with hepatocellular carcinoma, are not well known on the liver immune system, including natural killer (NK) cells. The aim of this study, therefore, was to investigate how acute PHT influences the functions and characteristics of liver\u2010resident NK (lr\u2010NK) cells using an acute PHT mouse model. Acute PHT decreased the number of tumor necrosis factor\u2013related apoptosis\u2010inducing ligand (TRAIL<jats:sup>+<\/jats:sup>) lr\u2010NK cells by about 20% and attenuated cytotoxic activity against the Hepa1\u20106 cell line by about 40%. Among various cytokine, only interleukin\u201033 (IL\u201033), which inhibits NK activity, significantly increased after portal vein ligation (PVL). Because lr\u2010NK cells highly expressed ST2\/IL\u201033R, IL\u201033 co\u2010culture significantly suppressed TRAIL expression on lr\u2010NK cells by about 50%, and IL\u201033 administration markedly decreased TRAIL expression and cytotoxic activity of lr\u2010NK cells. Furthermore, the TRAIL<jats:sup>+<\/jats:sup> NK cells population was maintained by anti\u2010IL33 antibody or following portosystemic shunt procedure even after PVL. Finally, we demonstrated that IL\u201033 decreased TRAIL expression in lr\u2010NK cells via AKT\u2013forkhead box O (FoxO) and mitogen\u2010activated protein kinase (MAPK) signaling. <jats:italic toggle=\"yes\">Conclusion<\/jats:italic>: This work demonstrates that PHT suppresses the TRAIL<jats:sup>+<\/jats:sup> lr\u2010NK cell population and antitumor activities in the liver. Additionally, Akt\u2010FoxO and MAPK signaling pathways attenuate the TRAIL expression in lt\u2010NK cells via IL\u201033 receptor in mice.<\/jats:p>","DOI":"10.1002\/hep4.2017","type":"journal-article","created":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T05:53:26Z","timestamp":1655790806000},"page":"2551-2564","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":14,"title":["Acute portal hypertension using portal vein ligation abrogates TRAIL expression of liver\u2010resident NK cells"],"prefix":"10.1097","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0882-5341","authenticated-orcid":false,"given":"Yuki","family":"Imaoka","sequence":"first","affiliation":[{"name":"Department of Gastroenterological and Transplant Surgery,Graduate School of Biomedical and Health Sciences,Hiroshima University 1\u20102\u20103,Hiroshima,Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koki","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological and Transplant Surgery,Graduate School of Biomedical and Health Sciences,Hiroshima University 1\u20102\u20103,Hiroshima,Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5433-5303","authenticated-orcid":false,"given":"Masahiro","family":"Ohira","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological and Transplant Surgery,Graduate School of Biomedical and Health Sciences,Hiroshima University 1\u20102\u20103,Hiroshima,Japan"},{"name":"Medical Center for Translational and Clinical Research Hiroshima University Hospital,Hiroshima,Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouki","family":"Imaoka","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological and Transplant Surgery,Graduate School of Biomedical and Health Sciences,Hiroshima University 1\u20102\u20103,Hiroshima,Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Yano","sequence":"additional","affiliation":[{"name":"Department of Surgery,Hiroshima City Hiroshima Citizens Hospital,Hiroshima,Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Nakano","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological and Transplant Surgery,Graduate School of Biomedical and Health Sciences,Hiroshima University 1\u20102\u20103,Hiroshima,Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological and Transplant Surgery,Graduate School of Biomedical and Health Sciences,Hiroshima University 1\u20102\u20103,Hiroshima,Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Ohdan","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological and Transplant Surgery,Graduate School of Biomedical and Health Sciences,Hiroshima University 1\u20102\u20103,Hiroshima,Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,6,20]]},"reference":[{"key":"hep42017-bib-0001-20241118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.hpb.2018.07.005","article-title":"Impact of clinically significant portal hypertension on outcomes after partial hepatectomy for hepatocellular carcinoma: a systematic review and meta\u2010analysis","volume":"21","year":"2019","journal-title":"HPB (Oxford)"},{"key":"hep42017-bib-0002-20241118","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1002\/bjs.8861","article-title":"Intraoperative portal venous pressure and long\u2010term outcome after curative resection for hepatocellular carcinoma","volume":"99","year":"2012","journal-title":"Br J Surg"},{"key":"hep42017-bib-0003-20241118","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1097\/SLA.0b013e3182a64b38","article-title":"Posthepatectomy portal vein pressure predicts liver failure and mortality after major liver resection on noncirrhotic liver","volume":"258","year":"2013","journal-title":"Ann Surg"},{"key":"hep42017-bib-0004-20241118","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1007\/s00330-017-5145-9","article-title":"Portal hypertension is associated with poor outcome of transarterial chemoembolization in patients with hepatocellular carcinoma","volume":"28","year":"2018","journal-title":"Eur Radiol"},{"key":"hep42017-bib-0005-20241118","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/hep.27864","article-title":"Impact of clinically evident portal hypertension on the course of hepatocellular carcinoma in patients listed for liver transplantation","volume":"62","year":"2015","journal-title":"Hepatology"},{"key":"hep42017-bib-0006-20241118","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1245\/s10434-008-0222-6","article-title":"Induction of tumor growth after preoperative portal vein embolization: is it a real problem?","volume":"16","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"hep42017-bib-0007-20241118","doi-asserted-by":"crossref","first-page":"G1534","DOI":"10.1152\/ajpgi.00503.2006","article-title":"Portal branch ligation induces a hepatic arterial buffer response, microvascular remodeling, normoxygenation, and cell proliferation in portal blood\u2010deprived liver tissue","volume":"292","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"hep42017-bib-0008-20241118","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/j.1478-3231.2005.01138.x","article-title":"Tumor growth\u2010promoting cellular host response during liver atrophy after portal occlusion","volume":"25","year":"2005","journal-title":"Liver Int"},{"key":"hep42017-bib-0009-20241118","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0065-2776(08)60664-1","article-title":"Biology of natural killer cells","volume":"47","year":"1989","journal-title":"Adv Immunol"},{"key":"hep42017-bib-0010-20241118","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1002\/1521-4141(2001010)31:10<3121::AID-IMMU3121>3.0.CO;2-4","article-title":"CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells","volume":"31","year":"2001","journal-title":"Eur J Immunol"},{"key":"hep42017-bib-0011-20241118","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1615\/CritRevImmunol.v31.i1.40","article-title":"Regulation of NK cell repertoire and function in the liver","volume":"31","year":"2011","journal-title":"Crit Rev Immunol"},{"key":"hep42017-bib-0012-20241118","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/tri.13536","article-title":"Everolimus enhances TRAIL\u2010mediated anti\u2010tumor activity of liver resident natural killer cells in mice","volume":"33","year":"2020","journal-title":"Transpl Int"},{"key":"hep42017-bib-0013-20241118","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/hep.21035","article-title":"Difference in cytotoxicity against hepatocellular carcinoma between liver and periphery natural killer cells in humans","volume":"43","year":"2006","journal-title":"Hepatology"},{"key":"hep42017-bib-0014-20241118","first-page":"3226","article-title":"Adoptive immunotherapy with liver allograft\u2010derived lymphocytes induces anti\u2010HCV activity after liver transplantation in humans and humanized mice","volume":"119","year":"2009","journal-title":"J Clin Invest"},{"key":"hep42017-bib-0015-20241118","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/83416","article-title":"Involvement of tumor necrosis factor\u2010related apoptosis\u2010inducing ligand in surveillance of tumor metastasis by liver natural killer cells","volume":"7","year":"2001","journal-title":"Nat Med"},{"key":"hep42017-bib-0016-20241118","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/hep.20204","article-title":"Liver NK cells expressing TRAIL are toxic against self hepatocytes in mice","volume":"39","year":"2004","journal-title":"Hepatology"},{"key":"hep42017-bib-0017-20241118","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1097\/01.tp.0000250935.41034.2d","article-title":"Adoptive transfer of TRAIL\u2010expressing natural killer cells prevents recurrence of hepatocellular carcinoma after partial hepatectomy","volume":"82","year":"2006","journal-title":"Transplantation"},{"key":"hep42017-bib-0018-20241118","article-title":"Hepatic irradiation persistently eliminates liver resident NK cells","volume":"13","year":"2018","journal-title":"PLoS One"},{"key":"hep42017-bib-0019-20241118","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/imr.12619","article-title":"Interleukin\u201033 (IL\u201033): A nuclear cytokine from the IL\u20101 family","volume":"281","year":"2018","journal-title":"Immunol Rev"},{"key":"hep42017-bib-0020-20241118","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1002\/eji.201041360","article-title":"IL\u201033 induces skin inflammation with mast cell and neutrophil activation","volume":"41","year":"2011","journal-title":"Eur J Immunol"},{"key":"hep42017-bib-0021-20241118","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s12079-018-0464-4","article-title":"A network map of IL\u201033 signaling pathway","volume":"12","year":"2018","journal-title":"J Cell Commun Signal"},{"key":"hep42017-bib-0022-20241118","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.4049\/jimmunol.1701147","article-title":"Postoperative portal hypertension enhances alloimmune responses after living\u2010donor liver transplantation in patients and in a mouse model","volume":"203","year":"2019","journal-title":"J Immunol"},{"key":"hep42017-bib-0023-20241118","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/labinvest.3700210","article-title":"Splenic transposition is superior to caudal shunt as a model of murine total hepatic ischemia","volume":"85","year":"2005","journal-title":"Lab Invest"},{"key":"hep42017-bib-0024-20241118","doi-asserted-by":"crossref","first-page":"967","DOI":"10.4049\/jimmunol.0903245","article-title":"Osteopontin expressed in tubular epithelial cells regulates NK cell\u2010mediated kidney ischemia reperfusion injury","volume":"185","year":"2010","journal-title":"J Immunol"},{"key":"hep42017-bib-0025-20241118","doi-asserted-by":"crossref","first-page":"G542","DOI":"10.1152\/ajpgi.00398.2014","article-title":"Oncostatin M induces IL\u201033 expression in liver endothelial cells in mice and expands ST2+CD4+ lymphocytes","volume":"309","year":"2015","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"hep42017-bib-0026-20241118","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1038\/onc.2008.21","article-title":"The FoxO code","volume":"27","year":"2008","journal-title":"Oncogene"},{"key":"hep42017-bib-0027-20241118","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0092-8674(00)80595-4","article-title":"Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor","volume":"96","year":"1999","journal-title":"Cell"},{"key":"hep42017-bib-0028-20241118","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/JLB.3A0120-379RR","article-title":"IL\u201033 promotes type 1 cytokine expression via p38 MAPK in human NK cells","volume":"107","year":"2020","journal-title":"J Leukoc Biol"},{"key":"hep42017-bib-0029-20241118","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s12026-012-8283-9","article-title":"IL\u201033\/ST2 axis in inflammation and immunopathology","volume":"52","year":"2012","journal-title":"Immunol Res"},{"key":"hep42017-bib-0030-20241118","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.coi.2014.09.004","article-title":"IL\u201033: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy","volume":"31","year":"2014","journal-title":"Curr Opin Immunol"},{"key":"hep42017-bib-0031-20241118","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1111\/j.1478-3231.2012.02802.x","article-title":"IL\u201033 and HMGB1 alarmins: sensors of cellular death and their involvement in liver pathology","volume":"32","year":"2012","journal-title":"Liver Int"},{"key":"hep42017-bib-0032-20241118","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.4049\/jimmunol.1101977","article-title":"Endogenous IL\u201033 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel Il\u201033\u2010LacZ gene trap reporter strain","volume":"188","year":"2012","journal-title":"J Immunol"},{"key":"hep42017-bib-0033-20241118","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/intimm\/dxn060","article-title":"IL\u201033 amplifies both Th1\u2010 and Th2\u2010type responses through its activity on human basophils, allergen\u2010reactive Th2 cells, iNKT and NK cells","volume":"20","year":"2008","journal-title":"Int Immunol"},{"key":"hep42017-bib-0034-20241118","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/eji.200838575","article-title":"The pro\u2010Th2 cytokine IL\u201033 directly interacts with invariant NKT and NK cells to induce IFN\u2010gamma production","volume":"39","year":"2009","journal-title":"Eur J Immunol"},{"key":"hep42017-bib-0035-20241118","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.canlet.2013.03.002","article-title":"Transgenic expression of IL\u201033 activates CD8(+) T cells and NK cells and inhibits tumor growth and metastasis in mice","volume":"335","year":"2013","journal-title":"Cancer Lett"},{"key":"hep42017-bib-0036-20241118","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.3389\/fimmu.2018.02601","article-title":"The pleiotropic immunomodulatory functions of IL\u201033 and its implications in tumor immunity","volume":"9","year":"2018","journal-title":"Front Immunol"},{"key":"hep42017-bib-0037-20241118","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1002\/eji.201141417","article-title":"ST2 deletion enhances innate and acquired immunity to murine mammary carcinoma","volume":"41","year":"2011","journal-title":"Eur J Immunol"},{"key":"hep42017-bib-0038-20241118","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1002\/ijc.28481","article-title":"Interleukin\u201033\/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells","volume":"134","year":"2014","journal-title":"Int J Cancer"},{"key":"hep42017-bib-0039-20241118","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.4049\/jimmunol.1800627","article-title":"IL\u201033 released in the liver inhibits tumor growth via promotion of CD4(+) and CD8(+) T cell responses in hepatocellular carcinoma","volume":"201","year":"2018","journal-title":"J Immunol"},{"key":"hep42017-bib-0040-20241118","doi-asserted-by":"crossref","first-page":"30894","DOI":"10.18632\/oncotarget.25768","article-title":"ST2\/IL\u201033 signaling promotes malignant development of experimental squamous cell carcinoma by decreasing NK cells cytotoxicity and modulating the intratumoral cell infiltrate","volume":"9","year":"2018","journal-title":"Oncotarget"},{"key":"hep42017-bib-0041-20241118","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1186\/s12967-020-02661-w","article-title":"Exogenous interleukin\u201033 promotes hepatocellular carcinoma growth by remodelling the tumour microenvironment","volume":"18","year":"2020","journal-title":"J Transl Med"},{"key":"hep42017-bib-0042-20241118","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.immuni.2011.11.016","article-title":"The transcription factors T\u2010bet and Eomes control key checkpoints of natural killer cell maturation","volume":"36","year":"2012","journal-title":"Immunity"},{"key":"hep42017-bib-0043-20241118","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","article-title":"AKT\/PKB signaling: navigating the network","volume":"169","year":"2017","journal-title":"Cell"},{"key":"hep42017-bib-0044-20241118","doi-asserted-by":"crossref","first-page":"47928","DOI":"10.1074\/jbc.M207509200","article-title":"FOXO proteins regulate tumor necrosis factor\u2010related apoptosis inducing ligand expression. Implications for PTEN mutation in prostate cancer","volume":"277","year":"2002","journal-title":"J Biol Chem"},{"key":"hep42017-bib-0045-20241118","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.bbamcr.2011.03.010","article-title":"Akt, FoxO and regulation of apoptosis","volume":"1813","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"hep42017-bib-0046-20241118","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.immuni.2015.02.006","article-title":"Transcription factor Foxo1 is a negative regulator of natural killer cell maturation and function","volume":"42","year":"2015","journal-title":"Immunity"},{"key":"hep42017-bib-0047-20241118","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.3389\/fimmu.2019.01016","article-title":"Hematopoietic\u2010specific deletion of Foxo1 promotes NK cell specification and proliferation","volume":"10","year":"2019","journal-title":"Front Immunol"},{"key":"hep42017-bib-0048-20241118","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/cas.14709","article-title":"The blockade of interleukin\u201033 released by hepatectomy would be a promising treatment option for cholangiocarcinoma","volume":"112","year":"2021","journal-title":"Cancer Sci"},{"key":"hep42017-bib-0049-20241118","article-title":"Phase 2a randomized, placebo\u2010controlled study of anti\u2010IL\u201033 in peanut allergy","volume":"4","year":"2019","journal-title":"JCI Insight"}],"container-title":["Hepatology Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hep4.2017","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/hep4.2017","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/10.1002\/hep4.2017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T12:01:33Z","timestamp":1731931293000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1002\/hep4.2017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,20]]},"references-count":49,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1002\/hep4.2017","relation":{},"ISSN":["2471-254X","2471-254X"],"issn-type":[{"value":"2471-254X","type":"print"},{"value":"2471-254X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,20]]},"assertion":[{"value":"2021-12-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}